hedwigaihedwigaihedwigai

Workbooks for everyday work.

The ultimate AI-native data mcp.Diligence documents, lead reports and spreadsheets, researched from the original sources. Edit them with a sentence; they update themselves when a source changes.

Start a workbook

First workbook free.

Customer Stories

> find 50 leads for our industrial pumps and draft an outreach email to each

One line. That is the entire brief.

6 minutes later: qualified B2B sales leads across five product lines.

And every source it cited was really where it said it was. Not most of them. Every one.

See the run →

Works with your favorite AI productivity apps.

Your workbooks are there in the apps you already work in: ask a question, start a report, or update a spreadsheet right where you're at.

Claude Code
Claude
Codex
Cursor
Hermes
Any MCP app

Context is king.

A document is only as good as what it was written from. So a workbook goes to the primary sources that matter to you: SEC filings, FDA labels, clinical trial registries, customs records, procurement awards.

And to the files you already keep. Connect Google Drive, Dropbox, OneDrive or SharePoint, and it works from what is there.

If a source you need is missing, we add that data hose. That is our enterprise work: talk to us.

Every line cites the page or row it came from.

How it works.

01
Describe it. One sentence saying what the document is.
02
It does the work. It reads the primary sources and your own files, and cites each one.
03
Several AI models share it. Each takes the part it does best: gathering, writing, checking.
04
It updates itself. When a source changes, the workbook changes with it and tells you what moved.
05
You change it with a sentence. Ask in plain English and it rewrites the part you meant.

Give your agent the data MCP.

Connect the hedwigai MCP and your agent can ask, list, start and change workbooks. You speak in sentences; it makes the calls.

A short answer from your workbooks and programs, with the source it rests on. Nothing to wait for.

Is Moderna a biotech with a public float above $5B?

Your agent

ask · Is Moderna NASDAQ:MRNA a biotech company with public float above $5B?

{
  "answer": "yes",
  "claims": [{ "figure": "public float", "value": "$9.6B",
               "as_of": "2026-06-28" }],
  "sources": ["MRNA 10-K, cover page",
              "biotech-diligence-7fq2 · §Moderna"]
}

Yes. Moderna's public float was $9.6B as of June 28, per the cover of its 10-K.

What you can build.

A workbook is one document with one job. You don't maintain it; it arrives researched and finished, and it keeps itself up to date.

Lead reports

Who to sell to, and why now. Customs records, procurement awards and project wins, qualified against your own criteria, with an outreach email drafted for each.

US importers of heavy engineering equipment.

Diligence documents

The pack on a company, a target or a supplier. Filings, labels, trial results and investor decks, gathered and checked, with every claim linked to its source.

Diligence on eleven biotech companies.